You are here

Malignant Neoplasm of the Endometrium B045

Last amended 
17 March 2016

Current RMA Instruments:

Reasonable Hypothesis SOP
11 of 2016
Balance of Probabilities SOP
12 of 2016
Changes from previous Instruments:

SOP Bulletin 188

 ICD Coding:
  • ICD-9-CM Codes: 182.0
  • ICD-10-AM Codes: C54.1
Brief description

This SOP covers cancer of the lining of the uterus.

Confirming the diagnosis

Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.

The relevant medical specialist is a gynaecologist or gynaecological oncologist.

Diagnoses covered by SOP
  • Adenoacanthoma of the endometrium
  • Adenocarcinoma of the endometrium
  • Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
  • Carcinoma-in-situ of the endometrium
  • Carcinosarcoma of the endometrium
  • Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
  • Hodgkin's lymphoma of the endometrium*
  • Leiomyoma (fibroid) of the uterus#
  • Malignant neoplasm of the cervix*
  • non-Hodgkin's lymphoma of the endometrium*
  • soft tissue sarcoma of the endometrium*

 *another SOP applies, # nonSOP

Clinical onset

Clinical onset will be when the condition was first diagnosed.  It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.

Clinical worsening

The SOP has only an inability to obtain apropriate clinical management factor for worsening.  Timely treatment can alter the course of the condition.  Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.